Select the Abstracts by Number

Click    to view the poster

644   Estimating Changes in Subcutaneous Adipose Tissue (SAT) Using the Durnin Formulae in HIV-Infected Subjects.

645   Facial Lipoatrophy Associated with HAART: Usefulness of Cheek Measure and Factors Associated.

646   Body Shape Abnormalities in a Cohort of HIV- Infected Patients on First-Line HAART.

647   Body Composition Changes in HIV-Infected Men Consuming Self-Selected Diets During a Placebo-Controlled Inpatient Study of Cannabinoids.

648   Does Race Protect an Oriental Population from Developing Lipodystrophy in HIV-Infected Individuals on HAART?

649   Antiretroviral-Associated Lipodystrophy Syndrome in HIV- Infected Children.

650   Metabolic and Body Composition Changes in HIV- Infected Children on Antiretroviral Therapy.

651   HAART-Associated Lipodystrophy Is Not Correlated to Mitochondrial Abnormalities in PBLs from HIV-Infected Children.

652   HAART-Associated Changes in Body Fat Distribution and Bone Mineral Loss Are Detectable in HIV-Infected Children Even in the Absence of Clinical Evidence of Lipodystrophy.

653   Effects of Protease Inhibitors on Insulin, Insulin Resistance, and Lipids in Children and Adolescents.

654   Hepatitis C Virus Chronic Infection Constitutes a Risk Factor for Insulin Resistance in HIV/HVC Co-Infected Patients Undergoing Antiretroviral Therapy.

654B   Nevirapine Containing Potent Antiretroviral Therapy Results in Ananti- Atherogenic Plasma Lipid Profile: Results from the Atlantic Trial.